Insmed Beats Stock-Drop Suit Over Lung Disease Drug
A New Jersey federal judge on Thursday tossed a proposed class action alleging that Insmed Inc. misled investors over the likelihood that a lung disease drug would gain market approval in...To view the full article, register now.
Already a subscriber? Click here to view full article